Bert Benthem

Bert Benthem is a distinguished pharma entrepreneur with a robust background in metabolic research spanning more than 25 years in animals and humans, with a significant portion in industrial environments.

Throughout his career, Bert has amassed extensive expertise in line management, project management, and collaborations across various sites and therapeutic areas.

His work primarily revolves around spearheading projects focused on the discovery of small molecule and peptide therapeutics, often pioneering projects with innovative treatment approaches.

Bert has a proven track record of successfully transitioning candidate drugs from the Discovery phase to Development, showcasing his adeptness in the drug development process.

Moreover, he is well-versed in providing scientific mentorship to his peers and has established a robust network within the metabolic research domain.

Specializing in drug discovery for metabolic diseases, Bert Benthem remains at the forefront of cutting-edge research and innovation in the pharmaceutical industry.